20.92
0.16 (0.77%)
| Penutupan Terdahulu | 20.76 |
| Buka | 20.97 |
| Jumlah Dagangan | 22,767 |
| Purata Dagangan (3B) | 36,941 |
| Modal Pasaran | 186,933,952 |
| Harga / Pendapatan (P/E Ke hadapan) | 28.09 |
| Harga / Jualan (P/S) | 1.82 |
| Harga / Buku (P/B) | 30.62 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 12 Nov 2025 |
| Margin Keuntungan | -12.48% |
| Margin Operasi (TTM) | -8.88% |
| EPS Cair (TTM) | -1.34 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 26.40% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 121.96% |
| Nisbah Semasa (MRQ) | 2.77 |
| Aliran Tunai Operasi (OCF TTM) | -1.80 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 1.01 M |
| Pulangan Atas Aset (ROA TTM) | -4.72% |
| Pulangan Atas Ekuiti (ROE TTM) | -29.22% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Instruments & Supplies (US) | Menaik | Bercampur |
| Medical Instruments & Supplies (Global) | Bercampur | Menurun | |
| Stok | Sanara MedTech Inc. | Menurun | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | 1.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 3.0 |
| Purata Bergerak Teknikal | 1.5 |
| Osilator Teknikal | -4.0 |
| Purata | 0.50 |
|
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel. |
|
| Sektor | Healthcare |
| Industri | Medical Instruments & Supplies |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 66.47% |
| % Dimiliki oleh Institusi | 10.43% |
| Julat 52 Minggu | ||
| Median | 36.00 (72.08%) | |
| Jumlah | 1 Beli | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| HC Wainwright & Co. | 14 Nov 2025 | 36.00 (72.08%) | Beli | 21.54 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 19 Nov 2025 | Pengumuman | Sanara MedTech to Participate in the Piper Sandler 37th Annual Healthcare Conference on December 3rd |
| 12 Nov 2025 | Pengumuman | Sanara MedTech Inc. Reports Third Quarter 2025 Financial Results (Unaudited) |
| 11 Nov 2025 | Pengumuman | Sanara MedTech Inc. Announces Strategic Realignment to Focus on Surgical Business |
| 01 Oct 2025 | Pengumuman | Sanara MedTech to Report Third Quarter 2025 Financial Results on November 12, 2025 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |